As calls to regulate AI increase, the tech industry is fighting back with good ol' fashioned corporate persuasion campaigns.
Musk has a big rival in the battle to insert a computer chip in your brain.
The billionaire says that the patient who underwent the startup's experimental surgery is "recovering well."
The U.S. Department of Transportation fined the experimental biotech company for violations involving the movement of hazardous material.
Well, not actually. But the OpenAI CEO had his break out "tech-visionary" moment at the startup's inaugural Dev Day conference.
Elon Musk's Neuralink received approval for its first-in-human tests to assess whether its brain chip implants are safe.
Grimes said Musk walked in on her recording vocals for the game, antique gun in hand, and asked developers to add him his avatar.
The biographer talks to Gizmodo about his latest subject, AI, assembly lines and Ukraine.
Musk biographer Walter Isaacson says Elon is on a mission to create AGI. Plus: potential storm clouds on the robotaxi horizon.
A profile of the billionaire claims he hopes to use data harvested from Twitter users and Tesla's Full Self-Driving Cameras to train a powerful new AI model.
The UN says we're facing an existential threat to the "notion of human identity, freedom of thought, privacy, and memory.”
The OpenAI CEO and ChatGPT creator has a lot of interests—some of which are weirder than others.
Neuralink, Elon Musk's brain-computer interface company, said it's received FDA approval to begin testing its device in human subjects.
The Juicero, Cyberpunk 2077, and Google Glass—The Museum of Failure, currently open in Brooklyn, has it all.
Elon is obsessed with giving himself public deadlines, which would be way less embarrassing if he was as interested in meeting them.
The FDA reportedly rejected the brain implant company's first human trial approval bid, but the billionaire's biotech venture has kept trying.
In a Morgan Stanley conference, the billionaire made some outlandish claims, including that his social media platform will soon be profitable.
The biotech company, currently facing at least two federal investigations, has blown past multiple deadlines for FDA approval—now it is likely to miss another.
The Delaware Court of Chancery said it needs another round of briefings to determine whether Musk steered Tesla's board toward giving him his 2018 pay package.
The federal government is now investigating after an animal rights advocacy group accused the biotech company of flouting hazardous materials laws.
